세계의 불임 치료 시장 보고서(2025년)

Infertility treatment encompasses procedures designed to address reproductive challenges in both males and females. Infertility itself is characterized by the inability to achieve pregnancy following 12 months or more of regular, unprotected sexual activity. In females, factors such as endometriosis, uterine fibroids, or thyroid issues can contribute to this condition, while men experiencing fertility issues may present with low testosterone levels or diminished sperm counts.

The primary components constituting infertility treatment are equipment, media and consumables, and associated accessories. Equipment in this context refers to a wide range of tools, instruments, machinery, and materials employed for medical purposes in treating infertility in both genders. Various procedures, including assisted reproductive technology, artificial insemination, fertility-related surgeries, utilize a diverse array of drugs such as clomiphene citrate, letrozole, serophene, hormonal treatments, among others. Patients seeking infertility treatment typically fall into categories of female or male infertility, while end users of these treatments comprise hospitals, surgical clinics, cryobanks, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The infertility treatment market research report is one of a series of new reports from The Business Research Company that provides infertility treatment market statistics, including infertility treatment industry global market size, regional shares, competitors with an infertility treatment market share, detailed infertility treatment market segments, market trends and opportunities, and any further data you may need to thrive in the infertility treatment industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The infertility treatment market size has grown strongly in recent years. It will grow from $1.82 billion in 2024 to $1.97 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to growing awareness and education, changing lifestyles and environmental factors, rising incidence of male infertility, government initiatives and support, shift in social perceptions.

The infertility treatment market size is expected to see strong growth in the next few years. It will grow to $2.77 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to expanding access to fertility clinics, advances in reproductive medicine, innovations in gamete and embryo culture, advancements in male contraception, focus on oocyte quality improvement. Major trends in the forecast period include technological advancements in assisted reproductive technologies (art), increasing prevalence of infertility, expanding age of parenthood, fertility preservation services, nutritional and lifestyle interventions.

The forecast of 9.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. fertility clinics by inflating prices of IVF culture media and vitrification devices imported from Denmark and Japan, resulting in reduced success rates and higher out-of-pocket costs for patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The decline in the global fertility rate is a significant factor driving the growth of the infertility treatment market. The fertility rate at a specific age is defined as the number of children born alive to women of that age during the year, expressed as a percentage of the average annual population of women of that age. Globally, the fertility rate has been steadily decreasing due to various factors, including the increasing trend of late marriages and rising age-related infertility. This reduction in fertility rates has resulted in a marked increase in the demand for infertility treatment products that help determine the fertility window for both males and females. For example, in June 2022, the World Economic Forum, a Switzerland-based international non-governmental organization, reported that fertility rates have declined worldwide over the past 70 years, with a total decrease of 50% recorded in 2022. Thus, the decline in the global fertility rate is driving the demand for infertility treatment products.

The increasing demand for surrogacy is anticipated to drive the growth of the infertility treatment market in the future. Surrogacy is a reproductive arrangement in which a woman, known as the surrogate, carries and gives birth to a child for another individual or couple, referred to as the intended parents. This option is often pursued in infertility treatment when a woman or couple cannot carry a pregnancy due to medical issues, repeated pregnancy loss, or other fertility challenges. For example, in December 2022, The Australian Broadcasting Corporation, an Australia-based radio broadcasting station, reported that approximately 100 Australian women give birth to babies for other families each year through surrogacy. Therefore, the rising demand for surrogacy is fueling the growth of the infertility treatment market.

Technological innovation is a significant trend gaining traction in the infertility treatment market. Leading companies in this sector are concentrating on developing new technological solutions to enhance their market position. In July 2024, Nikon Corporation, a Tokyo-based company, introduced the ECLIPSE Ti2-I Motorized Inverted Microscope, specifically designed for micro-insemination procedures such as ICSI (Intracytoplasmic Sperm Injection) and IMSI (Intracytoplasmic Morphologically-Selected Sperm Injection). This cutting-edge microscope improves the workflow in reproductive medicine, particularly in infertility treatment, by facilitating the performance of intricate procedures for specialists.

Leading companies in the infertility treatment market are innovating products, such as pre-filled pens, to minimize errors in the fertility treatment process. These pre-filled pens reduce mistakes by providing pre-measured doses, thereby enhancing precision and convenience. Oxolife, a Spain-based company focused on embryo implantation and ovulation restoration, has developed a first-in-class product candidate called OXO-001. This groundbreaking treatment aims to improve the embryo implantation process, potentially increasing success rates in fertility treatments. OXO-001 is specifically designed to meet the unique needs in reproductive medicine, offering a novel solution for patients facing difficulties with ovulation and embryo implantation. By addressing these critical aspects of fertility, Oxolife aims to provide a valuable option for individuals and couples looking to conceive.

In June 2024, CooperSurgical, a U.S.-based company focused on women's health, acquired ZyMot Fertility for an undisclosed amount. This acquisition enables CooperSurgical to strengthen its presence in the fertility sector by integrating ZyMot's innovative solutions into its portfolio. ZyMot Fertility is a U.S.-based company that specializes in advanced technologies aimed at supporting reproductive health.

Major companies operating in the infertility treatment market are The Cooper Companies Inc., Cook Group Incorporated, Vitrolife AB, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Limited, IVFtech ApS, FUJIFILM Irvine Scientific Inc., The Baker Company Inc., Kitazato Corporation, Rocket Medical PLC, IHMedical A/S, Hamilton Thorne Ltd., Carl Zeiss AG, MedGyn Products Inc., DxNow Inc., Nidacon International AB, Gynotec B.V., SAR Healthline Pvt. Ltd., InVitroCare Inc., Boston IVF, Shady Grove Fertility LLC, CCRM Fertility Co. LLC, IVI-RMA Global, Fertility Centers of Illinois, New Hope Fertility Center, Pacific Fertility Center, Houston Fertility Institute, Sher Fertility Institute, Columbia Asia Fertility Centre, Bourn Hall Fertility Clinic, Manipal Fertility, Morpheus IVF, Nova IVF Fertility, Indira IVF, Bloom Fertility Centre, Cloudnine Fertility, Oasis Fertility, Apollo Fertility, Milann Fertility Center, Fakih IVF, Procrea Fertility, The Montreal Fertility Center, The Center for Reproductive Medicine, The Reproductive Medicine Group, The Fertility Institute

North America was the largest region in the infertility treatment market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the infertility treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infertility treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infertility treatment market includes revenues earned by entities by providing fertility preservation, genetic carrier screening, egg treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infertility Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infertility treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infertility treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infertility treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Equipment; Media And Consumables; Accessories
• 2) By Procedure: Assisted Reproductive Technology; Artificial Insemination; Fertility Surgeries; Other Infertility Treatment Procedures
• 3) By Drugs: Clomiphene Citrate; Letrozole; Serophene; Hormone Treatment; Other Drugs
• 4) By Patient Type: Female Infertility Treatment; Male Infertility Treatment
• 5) By End User: Hospitals And Surgical Clinics; Cryobanks; Research Institutes
• Subsegments:
• 1) By Equipment: In Vitro Fertilization (IVF) Equipment; Cryopreservation Equipment; Sperm And Embryo Storage Systems; Ultrasound Machines
• 2) By Media And Consumables: Culture Media; Sperm Processing Media; Embryo Transfer Media; Oocyte Preservation Media
• 3) By Accessories: Catheters; Needles And Syringes; Petri Dishes; Incubators
• Companies Mentioned: The Cooper Companies Inc.; Cook Group Incorporated; Vitrolife AB; Thermo Fisher Scientific Inc.; Esco Micro Pte. Ltd.; Genea Limited; IVFtech ApS; FUJIFILM Irvine Scientific Inc.; The Baker Company Inc.; Kitazato Corporation; Rocket Medical PLC; IHMedical A/S; Hamilton Thorne Ltd.; Carl Zeiss AG; MedGyn Products Inc.; DxNow Inc.; Nidacon International AB; Gynotec B.V.; SAR Healthline Pvt. Ltd.; InVitroCare Inc.; Boston IVF; Shady Grove Fertility LLC; CCRM Fertility Co. LLC; IVI-RMA Global; Fertility Centers of Illinois; New Hope Fertility Center; Pacific Fertility Center; Houston Fertility Institute; Sher Fertility Institute; Columbia Asia Fertility Centre; Bourn Hall Fertility Clinic; Manipal Fertility; Morpheus IVF; Nova IVF Fertility; Indira IVF; Bloom Fertility Centre; Cloudnine Fertility; Oasis Fertility; Apollo Fertility; Milann Fertility Center; Fakih IVF; Procrea Fertility; The Montreal Fertility Center; The Center for Reproductive Medicine; The Reproductive Medicine Group; The Fertility Institute
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Infertility Treatment Market Characteristics

3. Infertility Treatment Market Trends And Strategies

4. Infertility Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Infertility Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Infertility Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Infertility Treatment Market Growth Rate Analysis
• 5.4. Global Infertility Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Infertility Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Infertility Treatment Total Addressable Market (TAM)

6. Infertility Treatment Market Segmentation

• 6.1. Global Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Equipment
• Media and Consumables
• Accessories
• 6.2. Global Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Assisted Reproductive Technology
• Artificial Insemination
• Fertility Surgeries
• Other Infertility Treatment Procedures
• 6.3. Global Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clomiphene Citrate
• Letrozole
• Serophene
• Hormone Treatment
• Other Drugs
• 6.4. Global Infertility Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Female Infertility Treatment
• Male Infertility Treatment
• 6.5. Global Infertility Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals and Surgical Clinics
• Cryobanks
• Research Institutes
• 6.6. Global Infertility Treatment Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In Vitro Fertilization (IVF) Equipment
• Cryopreservation Equipment
• Sperm And Embryo Storage Systems
• Ultrasound Machines
• 6.7. Global Infertility Treatment Market, Sub-Segmentation Of Media And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Culture Media
• Sperm Processing Media
• Embryo Transfer Media
• Oocyte Preservation Media
• 6.8. Global Infertility Treatment Market, Sub-Segmentation Of Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Catheters
• Needles And Syringes
• Petri Dishes
• Incubators

7. Infertility Treatment Market Regional And Country Analysis

• 7.1. Global Infertility Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Infertility Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infertility Treatment Market

• 8.1. Asia-Pacific Infertility Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infertility Treatment Market

• 9.1. China Infertility Treatment Market Overview
• 9.2. China Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infertility Treatment Market

• 10.1. India Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infertility Treatment Market

• 11.1. Japan Infertility Treatment Market Overview
• 11.2. Japan Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infertility Treatment Market

• 12.1. Australia Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infertility Treatment Market

• 13.1. Indonesia Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infertility Treatment Market

• 14.1. South Korea Infertility Treatment Market Overview
• 14.2. South Korea Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infertility Treatment Market

• 15.1. Western Europe Infertility Treatment Market Overview
• 15.2. Western Europe Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infertility Treatment Market

• 16.1. UK Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infertility Treatment Market

• 17.1. Germany Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infertility Treatment Market

• 18.1. France Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infertility Treatment Market

• 19.1. Italy Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infertility Treatment Market

• 20.1. Spain Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infertility Treatment Market

• 21.1. Eastern Europe Infertility Treatment Market Overview
• 21.2. Eastern Europe Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infertility Treatment Market

• 22.1. Russia Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infertility Treatment Market

• 23.1. North America Infertility Treatment Market Overview
• 23.2. North America Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infertility Treatment Market

• 24.1. USA Infertility Treatment Market Overview
• 24.2. USA Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infertility Treatment Market

• 25.1. Canada Infertility Treatment Market Overview
• 25.2. Canada Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infertility Treatment Market

• 26.1. South America Infertility Treatment Market Overview
• 26.2. South America Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infertility Treatment Market

• 27.1. Brazil Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infertility Treatment Market

• 28.1. Middle East Infertility Treatment Market Overview
• 28.2. Middle East Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infertility Treatment Market

• 29.1. Africa Infertility Treatment Market Overview
• 29.2. Africa Infertility Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Infertility Treatment Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Infertility Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infertility Treatment Market Competitive Landscape And Company Profiles

• 30.1. Infertility Treatment Market Competitive Landscape
• 30.2. Infertility Treatment Market Company Profiles
  • 30.2.1. The Cooper Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cook Group Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Vitrolife AB Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Esco Micro Pte. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Infertility Treatment Market Other Major And Innovative Companies

• 31.1. Genea Limited
• 31.2. IVFtech ApS
• 31.3. FUJIFILM Irvine Scientific Inc.
• 31.4. The Baker Company Inc.
• 31.5. Kitazato Corporation
• 31.6. Rocket Medical PLC
• 31.7. IHMedical A/S
• 31.8. Hamilton Thorne Ltd.
• 31.9. Carl Zeiss AG
• 31.10. MedGyn Products Inc.
• 31.11. DxNow Inc.
• 31.12. Nidacon International AB
• 31.13. Gynotec B.V.
• 31.14. SAR Healthline Pvt. Ltd.
• 31.15. InVitroCare Inc.

32. Global Infertility Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infertility Treatment Market

34. Recent Developments In The Infertility Treatment Market

35. Infertility Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Infertility Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Infertility Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Infertility Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer